Updated
PulmonxLUNG · Healthcare
$2.56+0.00%
Market cap$111M
IndustryMedical Devices
Pulmonx (LUNG) Superinvestor holders
8 of the superinvestors we track hold Pulmonx (LUNG) in their latest 13F filings, $9M in total.
Summary
The largest holder is PRIMECAP Management (PRIMECAP Management Co), with $6M, 0.0% of the portfolio.
In their latest quarter: 1 opened a new position, 4 added, 2 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| PRIMECAP Management PRIMECAP Management Co |
Trimmed | 4,612,331 | $6M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 522,987 | $997,000 | 0.0% | Q3 2026 |
| Cliff Asness AQR Capital Management |
Added | 744,963 | $968,453 | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Added | 425,110 | $552,643 | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 327,528 | $425,787 | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
New position | 230,738 | $299,959 | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 86,575 | $112,548 | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Held | 11,028 | $14,336 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 8 |
| Q1 2026 | 7 |
| Q4 2025 | 7 |
| Q3 2025 | 7 |
| Q2 2025 | 10 |
| Q1 2025 | 10 |
| Q4 2024 | 8 |
| Q3 2024 | 9 |
Questions about Pulmonx
Which superinvestors own Pulmonx?
8 of the superinvestors we track hold Pulmonx (LUNG) in their latest 13F filings, $9M in total. PRIMECAP Management, Acadian, Cliff Asness, Jim Simons, David Shaw, Paul Marshall.
Who is the largest superinvestor holder of LUNG?
The largest holder is PRIMECAP Management (PRIMECAP Management Co), with $6M, 0.0% of the portfolio.
From Pulmonx's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.